860389P
Avanti
26:0-d4 Lyso PC
1-hexacosanoyl-d4-2-hydroxy-sn-glycero-3-phosphocholine, powder
Synonym(s):
1-hexacosanoyl(12,12,13,13-D4)-sn-glycero-3-phosphocholine
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Empirical Formula (Hill Notation):
C34H66D4NO7P
CAS Number:
Molecular Weight:
639.92
UNSPSC Code:
12352100
NACRES:
NA.25
Recommended Products
Assay
>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
form
powder
packaging
pkg of 1 × 1 mg (860389P-1mg)
pkg of 1 × 5 mg (860389P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860389P
shipped in
dry ice
storage temp.
−20°C
General description
26:0-d4 Lyso PC is a deuterated lysophosphatidylcholine (lyso pc) in which 4 protons of hexacosanoyl are replaced by deuterium.
Application
26:0-d4 Lyso PC has been used as an internal standard to extract total very long chain fatty acids (VLCFAs) from brain, testes and adrenal glands.
Packaging
5 mL Amber Glass Screw Cap Vial (860389P-1mg)
5 mL Amber Glass Screw Cap Vial (860389P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Wedad Fallatah et al.
Disease models & mechanisms, 13(1) (2019-12-22)
Rhizomelic chondrodysplasia punctata (RCDP) is a rare genetic disorder caused by mutations in peroxisomal genes essential for plasmalogen biosynthesis. Plasmalogens are a class of membrane glycerophospholipids containing a vinyl-ether-linked fatty alcohol at the sn-1 position that affect functions including vesicular
Walter C Hubbard et al.
Molecular genetics and metabolism, 97(3), 212-220 (2009-05-09)
Newborn screening for X-linked adrenoleukodystrophy (X-ALD) has until now been limited in implementation because of the lack of an accepted standard methodology. We have previously reported a technique using LC-MS/MS analysis that could provide the basis for screening of newborns
A thyroid hormone-based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy
Hartley MD, et al.
Endocrinology, 158(5), 1328-1338 (2017)
John Williams et al.
Bioanalysis, 12(3), 143-158 (2020-02-14)
Aim: Very long chain fatty acids (VLCFAs) have been identified as biomarkers for several peroxisomal disorders necessitating the need for reliable biomarker assays in particular C20, C22, C24, C26 in cerebrospinal fluid (CSF). Until now no absolute quantitation assay for
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service